Citius Pharmaceuticals (CTXR) announced that it has entered into definitive agreements for the purchase of an aggregate of 12M shares of its ...

Net income: US$627.0k (up from US$579.0k loss in 3Q 2023). Profit margin: 6.1% (up from net loss in 3Q 2023). The move to ...

It's been a sad week for Marinus Pharmaceuticals, Inc. ( NASDAQ:MRNS ), who've watched their investment drop 14% ...

After reaching a $6.01 billion deal with 3M to settle the largest mass tort litigation in U.S. history, lawyers for the ...

The company will not receive any proceeds from the resale of the shares by the selling stockholders in this offering. Published first on ...

Many local pharmaceutical companies face high costs and struggle to meet international quality standards. According to the World Health Organization (WHO), fewer than 10% of medicines manufactured in ...

Analysts have recently evaluated Lexicon Pharmaceuticals and provided 12-month price targets. The average target is $9.2, ...

The United States Agency for International Development has announced a $2.3m commitment to procure 4.8 million doses of ...

During the last three months, 24 analysts shared their evaluations of Alnylam Pharmaceuticals ALNY, revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ...